The store will not work correctly when cookies are disabled.
6-(3-(4-Fluorobenzyloxy)phenyl)-5-phenylimidazo[2,1-b]thiazole
ID: ALA4860667
PubChem CID: 163409284
Max Phase: Preclinical
Molecular Formula: C24H17FN2OS
Molecular Weight: 400.48
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: Fc1ccc(COc2cccc(-c3nc4sccn4c3-c3ccccc3)c2)cc1
Standard InChI: InChI=1S/C24H17FN2OS/c25-20-11-9-17(10-12-20)16-28-21-8-4-7-19(15-21)22-23(18-5-2-1-3-6-18)27-13-14-29-24(27)26-22/h1-15H,16H2
Standard InChI Key: LGKXVQVZFJBDLT-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 33 0 0 0 0 0 0 0 0999 V2000
21.7747 -22.7542 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
20.9901 -23.0114 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9901 -23.8363 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.7747 -24.0934 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2594 -23.4238 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2053 -22.7542 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.7206 -23.4238 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2053 -24.0934 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2484 -26.2749 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5055 -25.4903 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9524 -24.8780 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1423 -25.0463 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8893 -25.8309 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4424 -26.4473 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8956 -23.4238 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4831 -24.1396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6581 -24.1396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2456 -23.4238 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6581 -22.7121 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4831 -22.7121 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2456 -24.8514 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.4206 -24.8499 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0070 -25.5637 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1824 -25.5608 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7688 -26.2737 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1801 -26.9898 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0095 -26.9886 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4193 -26.2750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7674 -27.7041 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 2 0
1 5 1 0
6 7 1 0
7 8 2 0
2 6 2 0
3 8 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
9 14 2 0
8 11 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
15 20 2 0
17 21 1 0
7 15 1 0
21 22 1 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 23 1 0
26 29 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 400.48 | Molecular Weight (Monoisotopic): 400.1046 | AlogP: 6.45 | #Rotatable Bonds: 5 |
Polar Surface Area: 26.53 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 3.31 | CX LogP: 6.10 | CX LogD: 6.10 |
Aromatic Rings: 5 | Heavy Atoms: 29 | QED Weighted: 0.34 | Np Likeness Score: -1.67 |
References
1. Zaraei SO, Sbenati RM, Alach NN, Anbar HS, El-Gamal R, Tarazi H, Shehata MK, Abdel-Maksoud MS, Oh CH, El-Gamal MI.. (2021) Discovery of first-in-class imidazothiazole-based potent and selective ErbB4 (HER4) kinase inhibitors., 224 [PMID:34237622] [10.1016/j.ejmech.2021.113674] |